Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Quality Systems (QSII) Completes EagleDream Health Buyout

Published 08/16/2017, 09:27 PM
Updated 07/09/2023, 06:31 AM

NextGen Healthcare Information Systems, a wholly-owned subsidiary of Irvine, CA-based Quality Systems, Inc. (NASDAQ:QSII) , recently completed the acquisition of EagleDream Health Inc. for roughly $26 million in cash.

EagleDream Health is a cloud-based analytics that optimizes understanding across clinical, financial and administrative data to enhanced practice performance.

Following the acquisition, NextGen Healthcare will gain facilities to provide enriching care experience and accelerate patient engagement for ambulatory clinics and health systems. Management further expects to achieve per capita cost efficiency as well as enhanced work-life balance for clinicians and staff.

Interestingly, the company has been in on an acquisition spree for long. Earlier this year, NextGen Healthcare had acquired Entrada, Inc. –provider of cloud-based solutions for healthcare – for $34 million. The company has already started gaining from this deal. Per the first-quarter fiscal 2018 results, Subscription revenues were significantly up on strength in Entrada. We believe the EagleDream Health acquisition will also prove accretive to the company.

Notably, the company has successfully added Revenue Cycle Management (RCM) solutions, Analytics, Patient Management and Regulatory and Clinical tools to its product portfolio through acquisitions. We believe that the company will continue to pursue strategic acquisitions that will not only expand its product portfolio but also strengthen its competitive position.

Per a report byMedGadget, the healthcare information systems market is expected to reach a value of $53.2 billion by 2019, at a CAGR of 7.1%.

Considering the market potential and Quality Systems’ current developments, this acquisition seems to be a strategic one.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Quality Systems has been gaining investor confidence on consistent positive results. Over the past three months, the company’s share price has outperformed the industry. The stock has gained 13.1%, higher than the industry’s gain of 4.6%. The company has also outperformed the 4.3% gain of the S&P 500 market over the same time frame.

However, the healthcare information systems and services market is highly competitive. Also, the industry is exceedingly fragmented and includes numerous players like athenahealth, Inc. (NASDAQ:ATHN) and McKesson Corporation (NYSE:MCK) , among others.

Zacks Rank & A Key Pick

Quality Systems currently has a Zacks Rank #3 (Hold). A better-ranked medical stock is Edwards Lifesciences Corporation (NYSE:EW) , with a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Edwards Lifesciences has a long-term expected earnings growth rate of 15.2%. The stock has gained around 28.8% over the last six months.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>



athenahealth, Inc. (ATHN): Free Stock Analysis Report

Quality Systems, Inc. (QSII): Free Stock Analysis Report

Edwards Lifesciences Corporation (EW): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


McKesson Corporation (MCK): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.